Drug intelligence / Profile preview

Baitongshu soft capsule

Development stage: Unknown
Lead developer: Xi'an Xintong Pharmaceutical Research
Administration: Oral

Overview

Baitongshu soft capsule is a Traditional Chinese Medicine (TCM) formulation developed by Xi'an Xintong Pharmaceutical Research Co., Ltd. for the treatment of primary dysmenorrhea. It is specifically indicated for patients presenting with the TCM pattern of 'qi stagnation and blood stasis.' The therapeutic approach of the formulation is to regulate qi and promote blood circulation to alleviate the pain associated with menstrual cycles. The drug has undergone Phase 2 clinical evaluation in China, where it was studied in a randomized, double-blind, placebo-controlled trial to assess its efficacy and safety over three consecutive menstrual cycles.

Brand names: Baitongshu
Other names: Baitongshu ruan jiaonang

Beyond the preview

Go deeper on Baitongshu soft capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baitongshu soft capsule.

Explore the full profile